NCT07384234 clinical landscape for Gastroesophageal junction adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development wh…

NCT07391267 clinical landscape for Metabolic dysfunction-associated steatotic liver disease: endpoints, sponsor, phase, geography, readouts, asset context an…

NCT07389187 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…

NCT07393867 clinical landscape for Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07392346 clinical landscape for Advanced gastric carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07394205 clinical landscape for CLDN18.2 positive Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white s…

NCT07391826 clinical landscape for Cachexia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07396090 clinical landscape for KRAS Mutant Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07404176 clinical landscape for Neuroendocrine Tumors: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07400315 clinical landscape for HER2 negative Gastroesophageal Junction Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and…

NCT07402551 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…

NCT07407283 clinical landscape for Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.